Analysis of expression and function of paucimannose - a new type of glycoslyation in vertebrate cells - in neural stem cells, glioblastoma cancer cells and neuroinflammatory processes
Analysis of expression and function of paucimannose - a new type of glycoslyation in vertebrate cells - in neural stem cells, glioblastoma cancer cells and neuroinflammatory processes
批准号:
291333515
负责人:
Privatdozentin Dr. Simone Diestel
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2019-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Protein glycosylation has received much attention during the last years since it became evident that it plays important regulatory roles during development and different pathophysiological conditions. Paucimannose is a mannosidic N-glycan composed of the monosaccharides mannose1-3fucose0-1N-acetylglucosamine2 that has classically been considered as a plant and invertebrate glycan. However, some recent publications demonstrated paucimannose expression in vertebrate cells in different physiological and pathophysiological conditions.We detected paucimannose specifically in early postnatal neural stem cells and in two different tumor cell lines. Expression of paucimannose in tumor cells was dependent on proliferation and differentiation of cells. Incubation of cells (postnatal neural stem cell and tumor cells) with Mannitou-antibody that specifically recognizes paucimannose resulted in significantly decreased cell proliferation. Furthermore, paucimannosidic proteins were identified in pathogene-infected human neutrophils indicating a possible role in inflammatory processes. Since the existence of paucimannose in vertebrates has only recently been demonstrated and almost nothing is known about its function in vertebrates, we aim to analyse the expression and functional mechanisms of paucimannose in specific stem cell populations and tumor cells with the proposed project in more detail. The expression and role of paucimannose in neuroinflammatory processes as occurring in Alzheimer dementia patients will also be analyzed. Furthermore, paucimannose carrying proteins will be identified. Finally, the function of paucimannose will be analysed in vitro and in vivo in different cell types (physiological and pathophysiological conditions). The results of this project could potentially represent a novel approach to understand stem cell development tumor progression and neuroinflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
-
批准号:82370751
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张明
-
依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
-
批准号:82371317
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:万杰清
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
-
批准号:82370820
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王天歌
-
依托单位:
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
-
批准号:32372856
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李隐侠
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
NFATc3转录调控MMP14介导少突胶质细胞瘤血管新生促肿瘤恶变的机制研究
-
批准号:32100563
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:齐琳
-
依托单位:
低氧相关lncRNA UTGF调控TGF-β信号传导及转移的作用及机制
-
批准号:32100573
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:伍梦芝
-
依托单位:
小鼠肺分支早期发育中肺上皮单细胞的时-空转录组的建立与分析
-
批准号:32070795
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:蔡军
-
依托单位: